Nexgel (NXGL) EBT Margin Growth (3y) (2021 - 2025)
Nexgel (NXGL) EBT Margin Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -19.00 |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 803.00 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -1,015.00 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 918.00 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -388.00 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -1,195.00 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -1,725.00 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.00 |
| 10 | Nexgel | 3.50 Mn | 2.13 Mn | 819,000.00 | 9,047.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,047.00 |
| Sep 30, 2025 | 19,397.00 |
| Jun 30, 2025 | 16,230.00 |
| Mar 31, 2025 | 43,947.00 |
| Dec 31, 2024 | 30,405.00 |
| Sep 30, 2024 | 31,525.00 |
| Jun 30, 2024 | 13,010.00 |
| Mar 31, 2024 | 19,219.00 |
| Dec 31, 2023 | 76,455.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 52,740.00 |
| Mar 31, 2023 | 8,151.00 |
| Dec 31, 2022 | 17,179.00 |
| Sep 30, 2022 | -16,933.00 |
| Mar 31, 2022 | 1,078.00 |
| Dec 31, 2021 | 49,532.00 |
| Sep 30, 2021 | -12,423.00 |